AbbVie Korea

South Korean company of AbbVie, the American biopharmaceutical company spun out of Abbott Laboratories in 2013 and headquartered at North Chicago in Illinois, with its Korean office in Seoul. Markets AbbVie's medicines in the country across immunology, oncology, neuroscience, eye care and virology, including adalimumab, risankizumab and upadacitinib and the Allergan aesthetics portfolio, and runs local clinical development, regulatory affairs and medical affairs.